Roche has acquired Ariosa Diagnostics, a privately-held US developer of blood tests used to detect Down syndrome and genetic abnormalities in the foetus.
The move gives Roche access to the noninvasive prenatal testing (NIPT) market. This is a market in which Illumina –...